Predicting progression in patients followed with active surveillance for low-risk prostate cancer

被引：1
|
作者：
Sternberg, Itay Aharon
Yu, Changhong
Paz, Gal Elimelech Keren
Kim, Philip H.
Bernstein, Melanie
Lakin, Paul
Kattan, Michael W.
Ehdaie, Behdar
Laudone, Vincent Paul
Scardino, Peter T.
Eastham, James Andrew
Touijer, Karim A.
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] Cleveland Clin, Cleveland, OH 44106 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Surg, Urol Serv, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 04期
关键词：
D O I：
10.1200/jco.2014.32.4_suppl.38
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
38
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Dutasteride and active surveillance of low-risk prostate cancer
    Fleshner, Neil E.
    LANCET, 2012, 379 (9826): : 1590 - 1590
  • [22] Active surveillance for low-risk prostate cancer: an update
    Lawrentschuk, Nathan
    Klotz, Laurence
    NATURE REVIEWS UROLOGY, 2011, 8 (06) : 312 - 320
  • [23] Active surveillance for low-risk prostate cancer: an update
    Nathan Lawrentschuk
    Laurence Klotz
    Nature Reviews Urology, 2011, 8 : 312 - 320
  • [24] Active surveillance for men with low-risk prostate cancer
    Sturch, Paul
    Kirby, Roger
    Challacombe, Ben
    TRENDS IN UROLOGY & MENS HEALTH, 2014, 5 (02) : 14 - 16
  • [25] Active Surveillance for Low-Risk Prostate Cancer Reply
    Lellig, Katja
    Buchner, Alexander
    Stief, Christian
    UROLOGE, 2015, 54 (06): : 870 - 870
  • [26] Urologists' Perceptions of Active Surveillance and Their Recommendations for Low-risk Prostate Cancer Patients
    Xu, Jinping
    Bock, Cathryn
    Janisse, James
    Schwartz, Kendra L.
    Triest, Jeffrey
    Cher, Michael L.
    Goodman, Michael
    UROLOGY, 2021, 155 : 83 - 89
  • [27] A SYSTEMATIC APPROACH TO DISCUSSING ACTIVE SURVEILLANCE TO PATIENTS WITH LOW-RISK PROSTATE CANCER
    Ehdaie, Behfar
    Asset, Melissa
    Benfante, Nicole
    Malhotra, Deepak
    Vickers, Andrew
    JOURNAL OF UROLOGY, 2016, 195 (04): : E409 - E409
  • [28] Active surveillance can reduce overtreatment in patients with low-risk prostate cancer
    Thomsen, Frederik Birkaebk
    Roder, Martin Andreas
    Hvarness, Helle
    Iversen, Peter
    Brasso, Klaus
    DANISH MEDICAL JOURNAL, 2013, 60 (02):
  • [29] How useful is immunohistochemistry in patients on active surveillance for low-risk prostate cancer?
    Eldefrawy, A.
    Ransford, G.
    Pan, D.
    Umar, S.
    Jorda, M.
    Soloway, M. S.
    BJU INTERNATIONAL, 2013, 111 : 38 - 39
  • [30] A Systematic Approach to Discussing Active Surveillance with Patients with Low-risk Prostate Cancer
    Ehdaie, Behfar
    Assel, Melissa
    Benfante, Nicole
    Malhotra, Deepak
    Vickers, Andrew
    EUROPEAN UROLOGY, 2017, 71 (06) : 866 - 871
12345